Exploration of binding mechanism of triclosan towards cancer markers using molecular docking and molecular dynamics

Prashant Bhardwaj1, G P Biswas2, Nibedita Mahata3

  • 1Department of Computer Science and Engineering, Indian Institute of Technology (Indian School of Mines), Dhanbad, 826004, India; Department of Computer Science and Engineering, National Institute of Technology, Agartala, 799046, India.

Chemosphere
|January 9, 2022
PubMed

Insights

Triclosan (TCS) may target proteins beyond hER, potentially contributing to cancer. This study used molecular docking and dynamics to identify new TCS protein interactions, revealing AIF and JNK as key players in TCS-mediated apoptosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Chemistry

Background:

  • Triclosan (TCS) is a synthetic chemical with endocrine-disrupting properties.
  • TCS is known to inhibit human enoyl-acyl carrier protein-reductase (hER), linked to diseases.
  • Potential cancer-related protein targets for TCS remain largely uncharacterized.

Purpose of the Study:

  • To investigate the protein binding patterns of Triclosan (TCS).
  • To identify novel protein targets of TCS involved in cancer signaling pathways.
  • To elucidate the molecular interactions between TCS and cancer-related proteins.

Main Methods:

  • Molecular docking and molecular dynamics (MD) simulations were employed using Discovery Studio 4.1.
  • Proteins were screened via CHARMM-based docking, with a CDOCKER energy threshold of -21.40 kcal/mol.
  • MD simulations analyzed protein-TCS complex stability using energy-time graphs, RMSD, and RMSF.

Main Results:

  • Docking identified potential interactions with FADD, RIP1, NIK, JNK, ASK1, Bcl-2, AIF, α-tubulin, and Actin.
  • MD simulations indicated varying stability, with RIP1 and Bcl-2 showing significant side-chain RMSF variations.
  • Apoptosis-Inducing Factor (AIF) and c-Jun N-terminal kinase (JNK) exhibited distinct binding patterns.

Conclusions:

  • Triclosan (TCS) may interact with multiple proteins involved in cancer signaling pathways.
  • Apoptosis-Inducing Factor (AIF) and c-Jun N-terminal kinase (JNK) are identified as pivotal proteins in TCS-mediated reactions.
  • Further research into TCS interactions with AIF and JNK could reveal new therapeutic strategies for cancer.

Related Concept Videos